News

Search:  

Latest News | 21 May 2012

FDA Puts Off Decision on Revoking National Drug Codes for Unapproved Products

0 Likes

The US Food and Drug Administration (FDA) announced in a Federal Register posting on 18 May it has not yet come to a conclusion regarding a Citizen Petition request to stop the issuance of national [Read More...]


Latest News | 1 May 2012

Report: FDA Meeting Review Goals Under PDUFA

0 Likes

The Government Accountability Office (GAO), the government agency tasked with reviewing and auditing government programs, has found the US Food and Drug Administration (FDA) to be meeting its [Read More...]


Latest News | 19 April 2012

Owe FDA Money? Don’t Bother Submitting an Application, Says CDER

0 Likes

A new Manual of Policies and Procedures (MAPP) document issued by the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) notes that if a pharmaceutical manufacturer [Read More...]


Latest News | 28 March 2012

AIDS Group Calls for Hamburg’s Resignation

0 Likes

The AIDS Healthcare Foundation (AHF) has launched an aggressive public advocacy campaign calling for the resignation of the US Food and Drug Administration’s top regulator, Commissioner Margaret [Read More...]


Latest News | 28 March 2012

BIO Analysis: Resubmissions After Third Round of FDA Review Not Worth the Effort

0 Likes

An analysis by the Biotechnology Industry Organization (BIO) of 748 new drug applications (NDAs) and biologics license applications (BLAs) shows a nearly 20% increase in the rate of approvals for [Read More...]


Latest News | 19 March 2012

Health Canada Accelerating Approvals to Ease Drug Shortages

0 Likes

Health Canada announced last week that it will expedite the review of 23 new drug applications (NDAs) in order to ease a growing shortage of medicines, reports Pharma Times.Federal Health Minister [Read More...]


Latest News | 28 February 2012

FDA Releases Guidance on Proper Size, Testing of Sprinkled Drug Products

0 Likes

The US Food and Drug Administration (FDA) released guidance 29 February that provides the agency’s current thinking about the proper size ranges and testing methods for drug products that are [Read More...]


Latest News | 6 February 2012

FDA Releases New Draft Guidance on Positron Emission Tomography Products

0 Likes

The US Food and Drug Administration (FDA) released new draft guidance for industry on 3 February that covers the regulation of positron emission tomography (PET) drugs. The guidance is intended to [Read More...]


Latest News | 13 January 2012

CDER: Guidance on NDA/BLA/ANDA Data Standards Coming in Mid-2012

0 Likes

The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) announced on 12 January that it is planning to release new regulatory requirements by mid-2012 for electronic [Read More...]